Karyopharm Therapeutics Inc. (KPTI) at a glance

Karyopharm Therapeutics Inc. (KPTI) is a micro-cap Healthcare company. It trades at $1.88, with a -129% profit margin and revenue growth of 16.8%. It does not pay a dividend. Vestovix scores it 54/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Momentum (13/100). Its volatility is roughly in line with the market.

Price

$1.88

Market cap

$215.3M

P/E ratio

n/a

Dividend yield

None

Beta

0.82

52-week range

$1.79 to $10.99